1. Home
  2. NUTX vs SPRY Comparison

NUTX vs SPRY Comparison

Compare NUTX & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$100.73

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$9.94

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
SPRY
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NUTX
SPRY
Price
$100.73
$9.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$252.50
$35.00
AVG Volume (30 Days)
207.7K
1.7M
Earning Date
11-19-2025
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
17.98
N/A
Revenue
$981,195,633.00
$142,772,000.00
Revenue This Year
$108.77
N/A
Revenue Next Year
$3.69
$126.72
P/E Ratio
$5.56
N/A
Revenue Growth
236.03
5459.66
52 Week Low
$40.67
$6.66
52 Week High
$193.07
$18.90

Technical Indicators

Market Signals
Indicator
NUTX
SPRY
Relative Strength Index (RSI) 31.57 43.87
Support Level $98.59 $9.60
Resistance Level $165.00 $10.74
Average True Range (ATR) 12.49 0.54
MACD -5.96 -0.10
Stochastic Oscillator 11.55 25.01

Price Performance

Historical Comparison
NUTX
SPRY

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: